WASHINGTON, Feb 23 (Reuters) - Salix Pharmaceuticals' diarrhea drug Xifaxan should be cleared to treat patients with a debilitating liver disorder, but more study would still be needed after approval, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results